$1.46
-0.02-1.35%
Last update: Sep 1, 9:28 AM
Aldeyra Therapeutics Inc Stock News
ALDXNASDAQ
Latest Aldeyra Therapeutics Stock News | NASDAQ:ALDX | Benzinga
Get the latest news on Aldeyra Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Aldeyra Therapeutics performance
Categories: All
Tuesday, July 28, 2026
Wednesday, July 15, 2026
Friday, June 05, 2026
Thursday, March 19, 2026
Wednesday, March 18, 2026
Tuesday, March 17, 2026
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- FDA Rejects Aldeyra's Dry Eye Drug For Third Time, Stock Crashes 68%
- Crude Oil Gains Around 2%; Elbit Systems Shares Jump On Upbeat Earnings
- Nasdaq Surges Over 100 Points; Academy Sports And Outdoors Posts Downbeat Earnings
- Aldeyra Therapeutics shares are trading lower...PRO
- Aldeyra Therapeutics Receives CRL From FDA Fo...PRO
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tuesday, December 16, 2025
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- FDA Extends Review Timeline For Aldeyra's Dry Eye Disease Drug
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
- Reported Earlier, Aldeyra Therapeutics Receiv...PRO
Thursday, November 13, 2025
Monday, November 10, 2025
Tuesday, October 28, 2025
Friday, October 10, 2025
Tuesday, October 07, 2025
Thursday, August 28, 2025
Tuesday, August 19, 2025
Thursday, July 24, 2025
Thursday, July 17, 2025
Thursday, June 26, 2025
Tuesday, June 17, 2025
Monday, May 19, 2025
Tuesday, May 06, 2025
Monday, May 05, 2025
Monday, April 07, 2025
Friday, April 04, 2025
Thursday, April 03, 2025
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- 11 Health Care Stocks Moving In Thursday's Intraday Session
- Crude Oil Dips 7%; ISM Services PMI Falls In March
- Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall
- FDA Rejects Aldeyra's Reproxalap For Dry Eye Disease Again, Citing Efficacy Concerns
- Aldeyra Therapeutics shares are trading lower...PRO
- Aldeyra Therapeutics Receives Complete Respon...PRO
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
